New film and online resources showcase the milestones, achievements and future of the pharmaceutical sector in the UK.
The Association of the British Pharmaceutical Industry (ABPI) has launched a new film and an accompanying suite of up-to-date online resources aimed at providing a comprehensive overview of the UK pharmaceutical industry.
A short film – ‘Only Just Begun’ (available via YouTube), produced in association with Artemis Films, celebrates the history of the UK pharmaceutical industry in changing the lives of patients, and the people involved in its past, present and future. It uses original footage and archive footage made available by ABPI members AstraZeneca, GSK, Novo Nordisk and Pfizer.
The new online content (available in full via SlideShare) features over 120 slides (split into chapters) that demonstrate the value of medicines and vaccines, the pharmaceutical sector’s worth to the UK economy, and the strides the sector has made to improve patient and health outcomes.
Aileen Thompson, ABPI Executive Director of Communications, said:
“Medicines and vaccines help us live longer, better lives and offer one of the greatest hopes we have for the future of human health. These new resources tell the story of what we do and why, and we hope they will inspire others to find out more about the life-changing discoveries, vaccines and medicines which our members deliver.”
## ENDS ##
ABPI Press OfficeEmail: email@example.comTelephone during work hours (9am to 5pm Monday to Friday): +44 (0) 20 7747 7147 or +44 (0) 20 7747 1441Telephone out of hours (5pm to 9am and weekends): +44 (0) 20 7747 1445
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. We represent companies who supply more than 80 per cent of all branded medicines used by the NHS and who are researching and developing the majority of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome disease.
Globally our industry is researching and developing more than 7,000 new medicines.
The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry for statutory consultation requirements including the pricing scheme for medicines in the UK.